IMC-S118AI

N/A

Report date: 2026/04/03 20:03:44

Base Information

Drug NameIMC-S118AI
Drug Alias NameIMC-S118AI
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHLA class I histocompatibility antigen, A alpha chain modulatorsProgrammed cell death protein 1 agonists
TargetsHLA class I histocompatibility antigen, A alpha chainProgrammed cell death protein 1
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesImmunocore Holdings PLC
China Registration ClassN/A

Develop Information

Active CompaniesImmunocore Holdings PLCImmunocore Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A